Results 101 to 110 of about 1,039,949 (275)
Drug Design, Development and Therapy, 2020 Sadia Sarwar,1,2 Jun Qing Yu,1 Humaira Nadeem,3 Fazlul Huq1 1Discipline of Biomedical Sciences, Sydney Medical School, The University of Sydney, Cumberland Campus, Sydney, NSW, Australia; 2Department of Pharmacognosy, Riphah Institute of Pharmaceutical ...
Sarwar S, Yu JQ, Nadeem H, Huq F
doaj
Market Structure and Drug Innovation [PDF]
An explosion of knowledge and a growing array of tools and technologies have transformed modern drug R&D, while its cost has risen by a sizable amount.
Pammolli, Fabio, Riccaboni, Massimo
core +1 more source
Assessment of degree of risk from sources of microbial contamination in cleanrooms; 2: surfaces and liquids [PDF]
, 2015 The degree of risk from microbial contamination of manufactured products in healthcare cleanrooms has been assessed in a series of three articles. The first article discussed airborne sources, and this second article considers surface contact and ...
Eaton, T., Whyte, W.
core
Practice of using gifts as promotional materials for marketing of pharmaceutical products in Bangladesh: a survey conducted on general physicians and representatives from pharmaceutical companies [PDF]
This article was published in Stamford Journal of Pharmaceutical Sciences [© 2011 Stamford Journal of Pharmaceutical Sciences] and the definite version is available at : http://www.banglajol.info/index.php/SJPS/article/view/10434/7712 The article website
Khosru, Kamrul Hasan, Sultana, Saki
core +2 more sources
مدیریت اطلاعات سلامت, 2010 Introduction: The purpose of this study was to evaluate the Iranian trend of research in pharmaceutical sciences published in international publication and to compare it with that in other countries in the Middle East and North Africa in 1996-2006 ...
Bita Mesgarpour +4 more
doaj
Adapting artificial intelligence into the evolution of pharmaceutical sciences and publishing: Technological darwinism. [PDF]
J Pharm Pharm Sci, 2023 Davies NM.
europepmc +1 more source
iScienceSummary: First-line macrolide therapy is encountering challenges due to the escalating incidence of macrolide-resistant Mycoplasma pneumoniae pneumonia (MRMPP).
Yun Lu +4 more
doaj +1 more source
Science AMA Series: Ask the Society of Environmental Toxicology and Chemistry (SETAC) anything about Pharmaceuticals in the environment! [PDF]
, 2017 SETAC North America, r Science
openalex +1 more source
Progress on Pharmaceutical Sciences/Pharmacy Postgraduate Education: a Bibliometric Perspective. [PDF]
J Pharm Innov, 2022 Huang Z +6 more
europepmc +1 more source
Drug Design, Development and Therapy, 2021 Sadia Sarwar,1,2 Abir A Alamro,3 Amani A Alghamdi,3 Komal Naeem,4 Salamat Ullah,5 Muazzam Arif,6 Jun Qing Yu,1 Fazlul Huq7 1Discipline of Biomedical Sciences, Sydney Medical School, The University of Sydney, Cumberland Campus, Sydney, NSW, Australia ...
Sarwar S +7 more
doaj